Publications by authors named "Jean-Luc Schmutz"

Article Synopsis
  • Dupilumab, the first monoclonal antibody approved for atopic dermatitis, has been linked to a notable increase in ocular side effects, reported in up to 37% of patients.
  • A study comparing patients on dupilumab to a reference group showed that 36% of those on dupilumab developed ocular issues, specifically severe allergic conjunctivitis and blepharitis.
  • The findings suggest a need for more research on risk factors for ocular diseases related to dupilumab, as well as a recommendation for ophthalmologist consultations prior to its use.
View Article and Find Full Text PDF

Scleromyxedema is a rare skin and systemic mucinosis that is usually associated with monoclonal gammopathy (MG). In this French multicenter retrospective study of 33 patients, we investigated the clinical and therapeutic features of MG-associated scleromyxedema. Skin molecular signatures were analyzed using a transcriptomic approach.

View Article and Find Full Text PDF

Background: Methylisothiazolinone (MI) is a preservative that is responsible for an epidemic of allergic contact dermatitis (ACD). Few studies have been published on the prognosis of patients with MI-induced ACD.

Objectives: To evaluate relapses of MI-induced ACD and difficulties in avoiding MI in patients who had received avoidance advice.

View Article and Find Full Text PDF

Nicorandil-induced ulcers remain often poorly recognised, with a late diagnosis and an inadequate management. We aimed to provide a clinical overview of the 148 spontaneously reported cases of nicorandil-induced ulcers to the French pharmacovigilance network between 2005 and 2014 and to complete this picture with worldwide published cases over the same period. Spontaneously reported nicorandil-induced ulcers were mainly mucosal (oral and anal) with a previous trauma in 23·0% of patients, revealed by a severe complication in 12·8% of cases.

View Article and Find Full Text PDF

Psoriasis has major physical, psychological, and social impacts: its management should not be restricted by individual financial considerations in Western countries as these have well-structured health systems and social/insurance coverage. We investigated if the socioeconomic characteristics of patients were associated with severity of psoriasis and access to healthcare. In a cross-sectional study, we included 903 patients with psoriasis that were consulting for the first time.

View Article and Find Full Text PDF